Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.

Schulman, Sam

Schulman, Sam.

Schulman S; Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada.

Semin Thromb Hemost ; 46(7): 772-776, 2020 10.

Article in English | MEDLINE | ID: covidwho-235561

Subject(s)

Betacoronavirus; Coronavirus Infections/blood; Pandemics; Pneumonia, Viral/blood; Thrombophilia/etiology; Venous Thromboembolism/etiology; Anticoagulants/administration & dosage; Anticoagulants/therapeutic use; Biomarkers; C-Reactive Protein/analysis; COVID-19; Coronavirus Infections/complications; Cytokines/blood; Fibrin Fibrinogen Degradation Products/analysis; Heparin, Low-Molecular-Weight/administration & dosage; Heparin, Low-Molecular-Weight/therapeutic use; Humans; Inflammation; Intensive Care Units/statistics & numerical data; Platelet Count; Pneumonia, Viral/complications; SARS-CoV-2; Sepsis/blood; Sepsis/complications; Thrombophilia/blood; Thrombophilia/drug therapy; Venous Thromboembolism/epidemiology; Venous Thromboembolism/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Thrombophilia / Venous Thromboembolism / Pandemics / Betacoronavirus Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Semin Thromb Hemost Year: 2020 Document Type: Article Affiliation country: S-0040-1710337

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google